Preclinical Pharmacokinetics (PK) and Pharmacodynamics (PD) Evaluation with Biocytogen
Speaker: John Charpentier, Ph.D, Scientific Content Specialist, Biocytogen Boston
- Defined pharmacokinetics/pharmacodynamics (PK/PD) and useful parameters to measure them
- Discussed Biocytogen’s platforms suited for antibody PK/PD studies
- Introduced humanized mouse models useful for evaluation of PK/PD
- In vivo case studies and examples
- Q&A session
